Join to View Full Profile
1250 E Marshall St# InternalRichmond, VA 23298
Phone+1 804-828-0450
Fax+1 804-828-7591
Dr. Ginder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gordon Ginder, MD is an oncology specialist located in Richmond, VA. His education spans from Johns Hopkins University School of Medicine to University of Iowa Hospitals and Clinics where he completed a fellowship in Hematology and Medical Oncology. Dr. Ginder previously served as a professor at the University of Minnesota Medical School. His experience includes specializing in various areas of oncology like amyloidosis, non-hodgkin lymphoma, hematologic oncology, myelodysplasia, and myelofibrosis. As a prolific contributor to his field, Dr. Ginder has been published multiple times in reputable journals, including the Proceedings of the National Academy of Sciences, Nature, Blood,New England Journal of Medicine and Advances in Cancer Research. His professional excellence has been recognized with election to both the Association of American Physicians, and The American Society for Clinical Investigation.
Education & Training
University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1979 - 1980
Laboratory of Molecular Biology, National Institutes of HealthPost-Doctoral Fellowship, 1977 - 1979
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1975 - 1977
Johns Hopkins University School of MedicineClass of 1975
Certifications & Licensure
VA State Medical License 1998 - 2026
MN State Medical License 1991 - 1999
IA State Medical License 1979 - 1991
MD State Medical License 1977 - 1984
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member AAP, 2000
- Elected Member The American Society for Clinical Investigation, 1991
Publications & Presentations
PubMed
- The role of multivalency in the association of the eight twenty-one protein 2 (ETO2) with the nucleosome remodeling and deacetylase (NuRD) complex.Glory Dan-Dukor, Shengzhe Shang, Gage O Leighton, Christopher R Travis, Timothy D Schwochert
Nucleic Acids Research. 2025-05-22 - 5 citationsSrc inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia.Xiaoyan Hu, Lin Li, Jewel Nkwocha, Maciej Kmieciak, Shengzhe Shang
Signal Transduction and Targeted Therapy. 2025-02-10 - 7 citationsAnalysis of the complex between MBD2 and the histone deacetylase core of NuRD reveals key interactions critical for gene silencing.Gage O Leighton, Shengzhe Shang, Sean Hageman, Gordon D Ginder, David C Williams Jr
Proceedings of the National Academy of Sciences of the United States of America. 2023-08-15
Press Mentions
Combination Treatment Strategy Dramatically Increases Cell Death in LeukemiaFebruary 27th, 2025- VCU Secures $9 Million Grant to Establish Cancer Control Equity Research Center in VirginiaDecember 16th, 2024
- Rural Cancer Patients Undergo Less Radiation Treatment and Experience Poorer OutcomesAugust 17th, 2022
Grant Support
- The Role of the MBD2-NuRD Complex in Gamma-Globin Gene SilencingVIRGINIA COMMONWEALTH UNIVERSITY2018–2029
- Cancer Center Support GrantNational Cancer Institute1997–2017
- Postdoctoral Training Program In Cancer BiologyNational Cancer Institute2000–2011
- Protocol-Specific Research SupportNational Cancer Institute2008–2010
- Developmental FundsNational Cancer Institute2008–2010
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
